In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and ...

San Francisco — For the treatment of coronary artery in-stent restenosis, angioplasty with a drug-coated balloon (AGENT DCB; Boston Scientific) was superior to conventional balloon angioplasty in ...

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to ...

Please provide your email address to receive an email when new articles are posted on . A sirolimus-eluting balloon was noninferior to drug-eluting stents in treating de novo coronary lesions. The ...

In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and effective outcomes. Their minimally invasive nature makes them a viable ...

Scripps Clinic interventional cardiologist Paul Teirstein, M.D., became the first in Southern California to use a newly approved drug-coated balloon to clear a clogged stent that previously had been ...

A Switzerland company has developed a potentially transformative drug-eluting balloon, and Cordis wants it bad enough to shell out $1.135 billion. Miami Lakes, FL-based Cordis said the acquisition of ...

In Germany, nearly 6 million people suffer from coronary heart disease. The disease is caused by calcium deposits which constrict the coronary arteries. Doctors generally use a stent to widen the ...

Please provide your email address to receive an email when new articles are posted on . A strategy using a drug-eluting balloon with minimal stenting was noninferior vs. a DES for ACS treatment. The ...

DUBLIN — A swallowable gastric balloon (Allurion Balloon, formerly known as Elipse) combined with daily subcutaneous injections of the glucagon-like peptide 1 (GLP-1) agonist liraglutide (Saxenda, ...